NCT05742867View on ClinicalTrials.gov

A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

July 10, 2024

Study Completion Date

July 10, 2024

Conditions
Urinary Bladder Neoplasms
Trial Locations (1)

27560

Local Institution - 0001, Morrisville

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT05742867 - A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder | Biotech Hunter | Biotech Hunter